Windtree Therapeutics, Inc.
WINT
$1.36
$0.032.26%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 77.14% | -217.66% | 298.27% | -16.47% | 32.96% |
| Total Depreciation and Amortization | -47.06% | 1,276.19% | -4.55% | -80.00% | -53.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -119.63% | 153.56% | -2,265.21% | 370.92% | -94.84% |
| Change in Net Operating Assets | -236.77% | 43.53% | 32.08% | 181.56% | 138.81% |
| Cash from Operations | -177.04% | 21.07% | 17.38% | 7.45% | -10.21% |
| Capital Expenditure | 100.00% | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | 100.00% | -- |
| Total Debt Issued | -87.97% | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 0.43% | -0.43% | -198.72% |
| Issuance of Common Stock | -- | -100.00% | 81.06% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 247.06% | 32.00% | -- | -- | -- |
| Cash from Financing | 335.45% | 54.16% | 98.46% | 323.61% | -102.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.80% | 61.11% | 37.20% | 25.74% | -156.82% |